A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis
Clinical Trial ID: NCT03809663
Learn about this trial.
Check the eligibility requirements, study details, and more.
Clinical Trial ID: NCT03809663
Check the eligibility requirements, study details, and more.